APA (7th ed.) Citation

RS, G., M, P., AA, S., SA, M., CM, F., AL, E., . . . MV, R. (2023). Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype. Clinical pharmacology and therapeutics, 113(5), 973. https://doi.org/10.1002/cpt.2735

Chicago Style (17th ed.) Citation

RS, Gammal, et al. "Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype." Clinical Pharmacology and Therapeutics 113, no. 5 (2023): 973. https://doi.org/10.1002/cpt.2735.

MLA (9th ed.) Citation

RS, Gammal, et al. "Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype." Clinical Pharmacology and Therapeutics, vol. 113, no. 5, 2023, p. 973, https://doi.org/10.1002/cpt.2735.